Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.12 USD | +6.11% | +9.54% | +21.09% |
Feb. 27 | North American Morning Briefing : Stock Futures -2- | DJ |
Feb. 26 | Citigroup Adjusts Price Target on Cogent Biosciences to $13 From $11, Maintains Buy Rating | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 1.33M | Capitalization | 681M |
---|---|---|---|---|---|
Net income 2024 * | -220M | Net income 2025 * | -232M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 514 x |
P/E ratio 2024 * |
-3.56
x | P/E ratio 2025 * |
-3.57
x | Employees | 164 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.68% |
Latest transcript on Cogent Biosciences, Inc.
1 day | +6.11% | ||
1 week | +9.54% | ||
Current month | +5.95% | ||
1 month | +11.42% | ||
3 months | +51.49% | ||
6 months | -19.37% | ||
Current year | +21.09% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Robbins
CEO | Chief Executive Officer | 48 | 20-10-22 |
John Green
DFI | Director of Finance/CFO | 43 | 18-05-31 |
Rachael Easton
CTO | Chief Tech/Sci/R&D Officer | - | 22-11-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arlene Morris
BRD | Director/Board Member | 72 | 19-07-25 |
Matthew Ros
BRD | Director/Board Member | 57 | 19-07-25 |
Todd Shegog
BRD | Director/Board Member | 59 | 21-02-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.05% | 237 M€ | -0.44% | - | |
0.04% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 7.12 | +6.11% | 891,876 |
24-04-19 | 6.71 | +1.51% | 1,518,301 |
24-04-18 | 6.61 | +1.23% | 1,061,611 |
24-04-17 | 6.53 | +1.08% | 2,008,780 |
24-04-16 | 6.46 | -0.62% | 1,035,007 |
Delayed Quote Nasdaq, April 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.09% | 681M | |
+2.49% | 96.73B | |
-0.20% | 21.31B | |
-16.61% | 21.21B | |
-5.48% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B | |
-21.79% | 8.56B |
- Stock Market
- Equities
- COGT Stock